← All trials
NCT04729088
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2020
- Primary completion
- Dec 20, 2020
- Completion date
- Dec 20, 2020
- First posted
- Jan 28, 2021
- Last posted
- Feb 1, 2021
- Enrollment
- —
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Biolab Sanus FarmaceuticaLead sponsor
- CAEP - Centro Avançado de Estudos e Pesquisas Ltda.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.